Ardelyx, Inc. (ARDX) Presents At Citi's Biopharma Back To School Conference Transcript
Question-and-Answer SessionSo I guess maybe to start out, Mike, if you want to just kind of summarize where you are with the business, 2 products that are gaining momentum.Michael RaabPresident, CEO & Director Sure. Thanks, Yigal, and to Citi for inviting us. I think we're at an incredibly exciting time for the evolution of the company where you look at the decision that we made to not participate in TDAPA. First, let's get that off the table because that's certainly a question that we get a lot of that, th ...